Prevention of recurrent nosebleeds in children. Some practical suggestions.
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002199:Capillary Permeability / Q000187:drug effects; D004844:Epistaxis / Q000517:prevention & control*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone; D007249:Inflammation / Q000188:drug therapy; D012008:Recurrence
D000893:Anti-Inflammatory Agents; D004966:Estrogens, Conjugated (USP); D006634:Histamine H1 Antagonists; D006854:Hydrocortisone